Brief: Intra-Cellular Therapies Upon Termination Of Deal, To Pay Johnson & Johnson Termination Fee Of $475.5 Million
Jan 13 (Reuters) - Intra-Cellular Therapies Inc
ITCI.O :
* INTRA-CELLULAR THERAPIES: UPON TERMINATION OF DEAL, UNDER
SPECIFIED CIRCUMSTANCES, CO TO PAY JOHNSON & JOHNSON TERMINATION
FEE OF $475.5 MILLION
Further company coverage: ITCI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intra-Cellular Therapies
See all newsBrief: Intra-Cellular Therapies stockholder filed lawsuit against co, board in NY Supreme Court
Intra-Cellular Therapies Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Apple, Caterpillar, Visa
Street View: New drug launches, ITCI deal to boost J&J's growth
J&J beats quarterly sales and profit estimates on cancer drug sales (updated)